Colfax (NYSE:CFX) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Colfax (NYSE:CFXGet Rating) in a research note issued on Saturday. The firm set a “hold” rating on the industrial products company’s stock.

Several other analysts also recently weighed in on CFX. Robert W. Baird decreased their price target on shares of Colfax from $198.00 to $141.00 in a research note on Wednesday, February 23rd. Stifel Nicolaus decreased their price target on shares of Colfax from $174.00 to $156.00 and set a “buy” rating for the company in a research note on Wednesday, February 23rd. Loop Capital initiated coverage on shares of Colfax in a research note on Wednesday, January 5th. They set a “hold” rating and a $135.00 price target for the company. KeyCorp decreased their price target on shares of Colfax from $180.00 to $156.00 and set an “overweight” rating for the company in a research note on Tuesday, March 15th. Finally, Seaport Res Ptn downgraded shares of Colfax from a “buy” rating to a “neutral” rating in a research note on Tuesday, February 8th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $147.00.

Colfax has a 12-month low of $35.66 and a 12-month high of $54.67. The company’s 50-day simple moving average is $112.45 and its 200 day simple moving average is $130.67. The stock has a market capitalization of $6.30 billion, a price-to-earnings ratio of 84.91, a PEG ratio of 0.77 and a beta of 2.12. The company has a quick ratio of 1.49, a current ratio of 2.25 and a debt-to-equity ratio of 0.45.

Colfax (NYSE:CFXGet Rating) last announced its earnings results on Tuesday, February 22nd. The industrial products company reported $1.77 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.06. Colfax had a return on equity of 7.41% and a net margin of 1.86%. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.01 billion. During the same quarter in the previous year, the business earned $1.53 earnings per share. The company’s revenue for the quarter was up 23.5% compared to the same quarter last year. Analysts expect that Colfax will post 2.39 earnings per share for the current fiscal year.

In other Colfax news, SVP Bradley J. Tandy sold 656 shares of the firm’s stock in a transaction dated Friday, February 25th. The stock was sold at an average price of $42.18, for a total value of $27,670.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Matthew L. Trerotola sold 6,465 shares of the firm’s stock in a transaction dated Wednesday, February 23rd. The stock was sold at an average price of $41.83, for a total value of $270,430.95. The disclosure for this sale can be found here. Insiders sold 200,919 shares of company stock valued at $8,192,906 in the last three months. 8.20% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. boosted its holdings in Colfax by 7.1% in the fourth quarter. BlackRock Inc. now owns 10,614,147 shares of the industrial products company’s stock worth $487,934,000 after acquiring an additional 701,442 shares in the last quarter. Morgan Stanley raised its stake in shares of Colfax by 102.3% in the third quarter. Morgan Stanley now owns 5,619,657 shares of the industrial products company’s stock worth $257,943,000 after purchasing an additional 2,841,927 shares during the last quarter. Diamond Hill Capital Management Inc. raised its stake in shares of Colfax by 1.0% in the fourth quarter. Diamond Hill Capital Management Inc. now owns 4,974,752 shares of the industrial products company’s stock worth $228,689,000 after purchasing an additional 49,026 shares during the last quarter. Starboard Value LP purchased a new position in shares of Colfax in the fourth quarter worth about $180,162,000. Finally, Southpoint Capital Advisors LP raised its stake in shares of Colfax by 4.6% in the fourth quarter. Southpoint Capital Advisors LP now owns 3,901,574 shares of the industrial products company’s stock worth $179,355,000 after purchasing an additional 172,758 shares during the last quarter. 91.99% of the stock is owned by institutional investors and hedge funds.

Colfax Company Profile (Get Rating)

Colfax Corp. operates as a diversified technology company. The firm provides orthopedic care and fabrication technology products and services to customers. It operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy.

Read More

Analyst Recommendations for Colfax (NYSE:CFX)

Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.